Skip to main content
Erschienen in: Supportive Care in Cancer 11/2017

26.05.2017 | Original Article

Timing to antibiotic therapy in septic oncologic patients presenting without hypotension

verfasst von: Kathleen Morneau, Gary B. Chisholm, Frank Tverdek, Jeffrey Bruno, Katy M. Toale

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sepsis accounts for only 2% of the hospitalizations worldwide but more than 17% of total in-hospital mortality. Inappropriate antimicrobial selection and delays in appropriate therapy have been associated with reduced survival in severe sepsis and septic shock. No studies to date have exclusively targeted septic oncologic patients without hypotension.

Methods

This study was a retrospective chart review of 100 adult cancer patients presenting to the emergency department with sepsis without hypotension. We investigated the effect of time to appropriate antibiotics on in-hospital mortality and hospital length of stay. It was hypothesized that increased time to antibiotic administration would worsen patient outcomes including in-hospital mortality and length of stay.

Results

Each 1-h delay in administration of appropriate antibiotic therapy increased the odds of in-hospital mortality by 16% (adjusted OR 1.16. 95% CI 1.04–1.34, p = 0.04). Time to appropriate antibiotics had no effect on hospital length of stay.

Conclusions

Time to appropriate antibiotics and in-hospital mortality were associated in this population of adult oncologic patients with sepsis without hypotension. Clinicians in the emergency department should strive to ensure the timely administration of a complete and appropriate empiric antibiotic regimen in septic patients with active cancer even in the absence of hypotension.
Literatur
2.
Zurück zum Zitat Levy M, Dellinger R, Townsend S et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38:367–374CrossRef Levy M, Dellinger R, Townsend S et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38:367–374CrossRef
3.
Zurück zum Zitat Danai PA, Moss M, Mannino DM, Martin GS (2006) The epidemiology of sepsis in patients with malignancy. Chest 129:1432–1440CrossRef Danai PA, Moss M, Mannino DM, Martin GS (2006) The epidemiology of sepsis in patients with malignancy. Chest 129:1432–1440CrossRef
4.
Zurück zum Zitat Larche J, Azoulay E, Fieux F et al (2013) Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29:1688–1695CrossRef Larche J, Azoulay E, Fieux F et al (2013) Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29:1688–1695CrossRef
5.
Zurück zum Zitat Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43–49CrossRef Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43–49CrossRef
6.
Zurück zum Zitat Regazzoni CJ, Irrazabal C, Luna CM, Poderoso JJ (2004) Cancer patients with septic shock: mortality predictors and neutropenia. Support Care Cancer 12:833–839CrossRef Regazzoni CJ, Irrazabal C, Luna CM, Poderoso JJ (2004) Cancer patients with septic shock: mortality predictors and neutropenia. Support Care Cancer 12:833–839CrossRef
7.
Zurück zum Zitat Rosolem MM, Rabello LS, Lisboa T et al (2013) Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care 27:301–307CrossRef Rosolem MM, Rabello LS, Lisboa T et al (2013) Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care 27:301–307CrossRef
8.
Zurück zum Zitat Williams MD, Braun LA, Cooper LM et al (2004) Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 8:R291–R298CrossRef Williams MD, Braun LA, Cooper LM et al (2004) Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 8:R291–R298CrossRef
9.
Zurück zum Zitat Zuber B, Tran TC, Aegerter P et al (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62CrossRef Zuber B, Tran TC, Aegerter P et al (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62CrossRef
10.
Zurück zum Zitat Nguyen HB, Oh J, Otero RM et al (2010) Standardization of severe sepsis management: a survey of methodologies in academic and community settings. J Emerg Med 38(2):122–132CrossRef Nguyen HB, Oh J, Otero RM et al (2010) Standardization of severe sepsis management: a survey of methodologies in academic and community settings. J Emerg Med 38(2):122–132CrossRef
11.
Zurück zum Zitat Shapiro NI, Howell MD, Talmor D et al (2006) Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 34:1025–1032CrossRef Shapiro NI, Howell MD, Talmor D et al (2006) Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 34:1025–1032CrossRef
12.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRef Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRef
13.
Zurück zum Zitat Kumar A, Ellis P, Arabi Y et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237–1248CrossRef Kumar A, Ellis P, Arabi Y et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237–1248CrossRef
14.
Zurück zum Zitat Zhang D, Micek ST, Kollef MH (2015) Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med 43:2133–2140CrossRef Zhang D, Micek ST, Kollef MH (2015) Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med 43:2133–2140CrossRef
15.
Zurück zum Zitat Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596CrossRef Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596CrossRef
16.
Zurück zum Zitat Ferrer R, Martin-Loeches I, Phillips G et al (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:1749–1755CrossRef Ferrer R, Martin-Loeches I, Phillips G et al (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:1749–1755CrossRef
17.
Zurück zum Zitat Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045–1053CrossRef Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045–1053CrossRef
18.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
19.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250–1256CrossRef Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250–1256CrossRef
20.
Zurück zum Zitat Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93CrossRef Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93CrossRef
21.
Zurück zum Zitat Vorwerk C, Loryman B, Coats TJ et al (2009) Prediction of mortality in adult emergency department patients with sepsis. Emerg Med J 26:254–258CrossRef Vorwerk C, Loryman B, Coats TJ et al (2009) Prediction of mortality in adult emergency department patients with sepsis. Emerg Med J 26:254–258CrossRef
22.
Zurück zum Zitat Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4(94):1–8 Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4(94):1–8
23.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
24.
Zurück zum Zitat Puskarich MA, Trzeciak S, Shapiro NI et al (2011) Association between timing of antibiotics and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 39:2066–2071CrossRef Puskarich MA, Trzeciak S, Shapiro NI et al (2011) Association between timing of antibiotics and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 39:2066–2071CrossRef
25.
Zurück zum Zitat Cheng AC, Buising KL (2009) Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia. Ann Emerg Med 53:618–624CrossRef Cheng AC, Buising KL (2009) Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia. Ann Emerg Med 53:618–624CrossRef
26.
Zurück zum Zitat Simonetti A, Viasus D, Garcia-Vidal C et al (2012) Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia. Clin Microbiol Infect 18:1149–1155CrossRef Simonetti A, Viasus D, Garcia-Vidal C et al (2012) Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia. Clin Microbiol Infect 18:1149–1155CrossRef
27.
Zurück zum Zitat Rosa RG, Goldani LZ (2014) Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother 58:3799–3809CrossRef Rosa RG, Goldani LZ (2014) Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother 58:3799–3809CrossRef
28.
Zurück zum Zitat Ko BS, Ahn S, Lee YS et al (2015) Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia. Support Care Cancer 23:2799–2804CrossRef Ko BS, Ahn S, Lee YS et al (2015) Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia. Support Care Cancer 23:2799–2804CrossRef
29.
Zurück zum Zitat Sterling SA, Miller WR, Pryor J et al (2015) The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med 43:1907–1915CrossRef Sterling SA, Miller WR, Pryor J et al (2015) The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med 43:1907–1915CrossRef
Metadaten
Titel
Timing to antibiotic therapy in septic oncologic patients presenting without hypotension
verfasst von
Kathleen Morneau
Gary B. Chisholm
Frank Tverdek
Jeffrey Bruno
Katy M. Toale
Publikationsdatum
26.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3754-0

Weitere Artikel der Ausgabe 11/2017

Supportive Care in Cancer 11/2017 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.